Difference between revisions of "Part:BBa K1694045"
Line 6: | Line 6: | ||
To prove that our scFv can actually bind on to the antigen on cancer cells, we connected each scFv with a different fluorescence protein. Therefore we could use fluorescence microscope to clearly observe if the E. coli has produced scFv proteins. Currently,we built three different scFv connected with their respectively fluorescence protein, which are Anti-VEGF+GFP, Anti-EGFR+RFP, Anti-HER2+BFP. When applied on cell staining, we can identify the antigen distribution on cancer cells by observing the fluorescence. Furthermore, if we use the three scFv simultaneously, we can also detect multiple markers. | To prove that our scFv can actually bind on to the antigen on cancer cells, we connected each scFv with a different fluorescence protein. Therefore we could use fluorescence microscope to clearly observe if the E. coli has produced scFv proteins. Currently,we built three different scFv connected with their respectively fluorescence protein, which are Anti-VEGF+GFP, Anti-EGFR+RFP, Anti-HER2+BFP. When applied on cell staining, we can identify the antigen distribution on cancer cells by observing the fluorescence. Furthermore, if we use the three scFv simultaneously, we can also detect multiple markers. | ||
− | + | <br> | |
− | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694002"> Lpp-OmpA-N</a><html> | + | Introduction of basic parts: <br> |
− | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694003"> Anti-VEGF </a><html> | + | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694002"> Lpp-OmpA-N</a><html><br> |
− | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694004"> Anti-EGFR </a><html> | + | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694003"> Anti-VEGF </a><html><br> |
− | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694005"> Anti-HER2 </a><html> | + | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694004"> Anti-EGFR </a><html><br> |
− | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694013"> OmpA-Anti-VEGF </a><html> | + | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694005"> Anti-HER2 </a><html><br> |
− | <html><a href="https://parts.igem.org/Part:BBa_K1694004">OmpA-Anti-EGFR </a><html> | + | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694013"> OmpA-Anti-VEGF </a><html><br> |
− | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694015">OmpA-Anti-HER2 </a><html> | + | <html><a href="https://parts.igem.org/Part:BBa_K1694004">OmpA-Anti-EGFR </a><html><br> |
+ | <html><a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1694015">OmpA-Anti-HER2 </a><html><br> | ||
[[File:TLB.png|600px|thumb|center|'''Fig.2''' Transformation of single plasmid]] | [[File:TLB.png|600px|thumb|center|'''Fig.2''' Transformation of single plasmid]] |
Revision as of 07:14, 22 September 2015
Pcons+B0034+Lpp-OmpA-N+scFv(Anti-HER2)+B0030+BFP+J61048
Introduction:
Transformation of single plasmid
To prove that our scFv can actually bind on to the antigen on cancer cells, we connected each scFv with a different fluorescence protein. Therefore we could use fluorescence microscope to clearly observe if the E. coli has produced scFv proteins. Currently,we built three different scFv connected with their respectively fluorescence protein, which are Anti-VEGF+GFP, Anti-EGFR+RFP, Anti-HER2+BFP. When applied on cell staining, we can identify the antigen distribution on cancer cells by observing the fluorescence. Furthermore, if we use the three scFv simultaneously, we can also detect multiple markers.
Introduction of basic parts:
Lpp-OmpA-N
Anti-VEGF
Anti-EGFR
Anti-HER2
OmpA-Anti-VEGF
OmpA-Anti-EGFR
OmpA-Anti-HER2
[[File:TLB.png|600px|thumb|center|'''Fig.2''' Transformation of single plasmid]]
'''Experiment'''
'''1.Cloning''' [[File:PROHBFPPCR.png|200px|thumb|left|'''Fig.3''' The PCR result of the Pcons+B0034+Lpp-OmpA-N+scFv(Anti-HER2)+B0030+BFP+J61048. The DNA sequence length is around 1900~2100 bp, so the PCR products should appear at 2100~2300 bp.]] After assemble the DNA sequences from the basic parts, we recombined each Pcons+B0034+Lpp-OmpA-N+scFv(Anti-HER2)+B0030+BFP+J61048 gene to PSB1C3 backbones and conducted a PCR experiment to check the size of each of the parts. The DNA sequence length of the these parts are around 1900~2100 bp. In this PCR experiment, the PCR products size should be near at 2100~2300 bp. The Fig.3 showed the correct size of this part, and proved that we successful ligated the sequence onto an ideal backbone. [[File:PROHBFPsss.png|600px|thumb|center|'''Fig.4''' Pcons+B0034+Lpp-OmpA-N+scFv(anti-HER2)+B0030+BFP+J61048]]'''2. Transformation of single plasmid'''
''' (1) Cell staining experiment:''' After creating the part of scFv and transforming them into our ''E. coli'', we were going to prove that our detectors have successfully displayed scFv of anti-HER2. To prove this, we have decided to undergo the cell staining experiment by using our ''E. coli'' to detect the EGFR in the SKOV-3 cancer cell lines. SKOV-3 is a kind of epithelial cell that expressed markers such as HER2.
''' (2) Staining results:'''
'''Modeling'''
In the modeling part, we discover optimum protein expression time by using the genetic algorithm in Matlab.We want to characterize the actual kinetics of this Hill-function based model that accurately reflects protein expression time.
When we have the simulated protein expression rate, the graph of protein production versus time can be drawn. Thus, we get the optimum protein production time Compared with the simulated protein expression rate of time, our experiment data quite fit the simulation.
[[File:WholeHER2-BFP.png|800px|thumb|center|From this graph, the orange curve is the simulated protein expression. The blue curve is our experimental data. By comparing the orange curve and the blue curve, we speculated that experimental error cause the undesired result.]] Sequence and Features